Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
General

Sanofi Expands US Diabetes Program with $35 Insulin Cap: Dagens industri

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Dagens industri

Key takeaways

  • Amidst market volatility, SH Pension, in a sponsored article in Dagens industri, emphasizes the stability of traditional insurance as a pension savings strategy
  • A recent Novus survey, cited in the article, reveals that 38% of Swedes express insecurity regarding their pension investments due to recent market fluctuations
  • Annelie Helsing, CEO of SH Pension, highlights the advantages of traditional insurance, a long-term savings option offering guaranteed, stable returns at a lower risk
Amidst market volatility, SH Pension, in a sponsored article in Dagens industri, emphasizes the stability of traditional insurance as a pension savings strategy. A recent Novus survey, cited in the article, reveals that 38% of Swedes express insecurity regarding their pension investments due to recent market fluctuations. Annelie Helsing, CEO of SH Pension, highlights the advantages of traditional insurance, a long-term savings option offering guaranteed, stable returns at a lower risk. She points out its historical resilience during market crises, including the 2008 financial crisis and the 2020 pandemic, attributing this to its diversified investment portfolio encompassing stocks, bonds, and real estate. SH Pension's returns, distributed through a bonus rate system that mitigates market volatility, have averaged 6.3% over the past five years, according to the article. Helsing recommends that savers, particularly those approaching retirement, consider reducing their investment risk to safeguard their capital against potential market downturns.

Related Topics

SanofidiabetesinsulinpharmaceuticalshealthcareUSAdrug pricing

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original